- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03135561
A Pedometer-based Intervention With and Without Email Counselling in General Practice
April 26, 2017 updated by: Tomáš Větrovský, Charles University, Czech Republic
A Pedometer-based Walking Intervention With and Without Email Counselling in General Practice: a Pilot Randomised Controlled Trial
A two-arm parallel randomised controlled trial comparing pedometer-based intervention with and without email counselling in a primary care setting.
Physically inactive patients from four general practices will be randomised to the pedometer-plus-email group or to the pedometer-alone group.
All patients will be instructed to gradually increase the daily number of steps to at least 10,000.
Patients in the pedometer-plus-email group will receive 8 counselling emails based on behavioural techniques.
The primary outcome will be change in average daily steps measured during 7-day period at baseline and at 12 weeks.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
37
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- physically inactive, i.e. takes less than 8,000 steps per day at baseline
- registered at the participating general practice,
- over 18 years of age,
- regular email user, and willing to use email for the purpose of the study,
- has a home computer with access to the Internet.
Exclusion Criteria:
- medical or psychiatric condition which the general practitioner considers as inappropriate for participating in the intervention (e.g., terminal illness, psychotic illness, chronic disorders or diseases that seriously influence the ability to be physically active, dementia or significant cognitive impairment, unable to move about independently),
- medical, personal of family condition which the general practitioner considers temporarily affects mean daily step count at baseline (e.g., acute illness, holiday or business trip),
- pregnant woman,
- currently engaging in regular sports or exercise (at least twice a week),
- failure to upload pedometer data to a website at baseline assessment,
- failure to give informed consent with the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: pedometer-plus-email
|
After randomisation, participants will receive a pedometer and will be instructed to wear the pedometer daily for the next four months, check the step count every evening and gradually increase their daily number of steps to at least 10,000.
They will also be required to upload data to a website at least once a week.
During the intervention period, patients will receive 8 counselling emails based on behavioural techniques.
|
Active Comparator: pedometer-only
|
After randomisation, participants will receive a pedometer and will be instructed to wear the pedometer daily for the next four months, check the step count every evening and gradually increase their daily number of steps to at least 10,000.
They will also be required to upload data to a website at least once a week.
There will be no further interaction during the intervention period unless they fail to upload data, in which case they will be offered technical support.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
average daily step count
Time Frame: 12 weeks
|
change in average daily steps measured during 7-day period at baseline and at 12 weeks
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
body weight
Time Frame: 12 weeks
|
measured to the nearest kg
|
12 weeks
|
systolic blood pressure
Time Frame: 12 weeks
|
measured to the nearest mmHg
|
12 weeks
|
diastolic blood pressure
Time Frame: 12 weeks
|
measured to the nearest mmHg
|
12 weeks
|
waist circumference
Time Frame: 12 weeks
|
recorded with a measurement tape to the nearest cm
|
12 weeks
|
hip circumference
Time Frame: 12 weeks
|
recorded with a measurement tape to the nearest cm
|
12 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
health-related quality of life
Time Frame: 12 weeks
|
assessed with the 36-Item Short Form Health Survey (SF-36)
|
12 weeks
|
anxiety
Time Frame: 12 weeks
|
assessed with the anxiety subscale of the Hospital Anxiety and Depression Scale
|
12 weeks
|
depression
Time Frame: 12 weeks
|
assessed with the depression subscale of the Hospital Anxiety and Depression Scale
|
12 weeks
|
self-efficacy
Time Frame: 12 weeks
|
assessed with the Czech version of the General Self-Efficacy scale
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Tomas Vetrovsky, MD, Charles University, Czech Republic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 12, 2015
Primary Completion (Actual)
September 29, 2016
Study Completion (Actual)
December 9, 2016
Study Registration Dates
First Submitted
April 26, 2017
First Submitted That Met QC Criteria
April 26, 2017
First Posted (Actual)
May 1, 2017
Study Record Updates
Last Update Posted (Actual)
May 1, 2017
Last Update Submitted That Met QC Criteria
April 26, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- Pedometer-plus-email
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Physical Activity
-
Istinye UniversityCompletedPhysical Activity | Youth | Physical Activity Barriers | Physical Activity FacilitatorsTurkey
-
Istanbul Kültür UniversityWithdrawnPhysical Activity Level | Physical Activity Awareness
-
Georgetown UniversityUniversity of PennsylvaniaCompletedPhysical Activity | Motor ActivityUnited States
-
Assistance Publique - Hôpitaux de ParisTerminatedPhysical Activity | Physical DisabilityFrance
-
University of Colorado, DenverCompletedPhysical Activity | Physical ImpairmentUnited States
-
PXL University CollegeHasselt UniversityNot yet recruitingPhysical Activity - Digital Phenotyping - Activity Tracking
-
University of ExtremaduraThe Spanish Ministry of Science, Innovation and UniversitiesRecruitingPhysical Activity | Cognition | Physical Fitness | AdolescentsSpain
-
Universitaet InnsbruckRecruiting
-
AdventHealth Translational Research InstituteWake Forest UniversityRecruiting
-
Wake Forest University Health SciencesMayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases... and other collaboratorsRecruitingPhysical ActivityUnited States
Clinical Trials on pedometer-plus-email
-
Meir Medical CenterTerminated
-
Leanne KayeUNC Lineberger Comprehensive Cancer Center; University of North CarolinaCompletedBreast Neoplasms | Sedentary Lifestyle | Survival Rate (Survivorship)United States
-
Aveiro UniversityFundação para a Ciência e a TecnologiaCompletedChronic Obstructive Pulmonary Disease (COPD)Portugal
-
University of FloridaCompletedAmbulation | Wearable DevicesUnited States
-
Institute for Clinical Evaluative SciencesCanadian Institutes of Health Research (CIHR); Ontario Agency for Health Protection... and other collaboratorsCompletedAntibiotic Initiation | Antibiotic DurationCanada
-
Harvard School of Public Health (HSPH)Massachusetts General HospitalCompletedOncologyUnited States
-
Rigshospitalet, DenmarkNovo Nordisk A/S; Copenhagen University Hospital at Herlev; Danish Cancer Society and other collaboratorsCompleted
-
Ege UniversityRecruitingCardiac Disease | Kidney Transplant; ComplicationsTurkey
-
Hospital for Special Surgery, New YorkMemorial Sloan Kettering Cancer CenterCompletedChronic Low Back PainUnited States
-
Sheba Medical CenterUnknown